Page 2576 - Cote clinical veterinary advisor dogs and cats 4th
P. 2576

Activated Partial Thromboplastin Time (aPTT)   1301


           due to inflammatory disease without bleeding    is  subject  to  observer  variability.  Difficult   Pearls
           tendency.                           venipuncture causing exposure to tissue factor   •  Insensitive test that may be useful cage side
  VetBooks.ir  Next Diagnostic Steps to Consider   Specimen Collection and Handling  •  Carriers of hemophilia (coagulation factors
                                                                                    for suspected warfarin-intoxicated dogs if
                                               and platelet activation may falsely shorten ACT.
                                                                                    aPTT unavailable.
           if Levels Are High
           Confirm with more sensitive tests (e.g., aPTT,
                                                                                    hereditary factor VII deficiency will not be
                                               prewarmed to 37°C. Mix by inversion, incubate
           platelet count).                    Whole blood into siliceous (gray top) tube,   are 40%-60% of normal) and beagles with
                                               at 37°C (purpose made heating block, water   detected.
           Drug Effects                        bath, or human axilla) and check for clot forma-
           Prolonged by anticoagulant therapy (e.g.,   tion every 5-10 seconds. Do not incubate in a   AUTHOR & EDITOR: Lois Roth-Johnson, DVM, PhD,
                                                                                  DACVP
           heparin), some antibiotics (newer lipoglyco-  closed palm, as it does not provide a consistent
           peptide  antibiotics, rarely used in veterinary   37°C environment.
           medicine, may interfere with factor Xa).
                                               Relative Cost:  $
           Lab Artifacts
           An in-office test. Any variation in protocol may
           alter results. Endpoint (visual clot detection)




            Activated Partial Thromboplastin Time (aPTT)



           Definition                           antagonism, factor dilution  (massive   •  Prolonged:
           Screening test for disorders of intrinsic and   transfusion/fluid replacement)  ○   Inappropriate ratio of plasma to citrate:
           common coagulation pathways. Named for   •  Severe  von  Willebrand  disease:  von  Wil-  underfilling of citrate tube, polycythemia
           additives (e.g., partial thromboplastins, surface   lebrand factor stabilizes factor VIII, so severe   ○   Sample  collection:  Difficult/traumatic
           activators) used to activate coagulation in vitro.   deficiency (<30%) can lead to increased   venipuncture, improper storage
           During testing calcium is added to overcome   aPTT.                      ○   Anti-phospholipid antibodies: rarely
           the effect of citrate, and aPTT is the time from   •  Anticoagulant therapy (e.g., heparin, warfarin)  documented in animals, but may inter-
           addition of calcium chloride to clot detection.                            fere with phospholipids in testing phase
                                               Next Diagnostic Steps to Consider      even though animals don’t have signs of
           Synonym(s)                          if Levels Are High                     hypocoagulation
           aPTT, APTT, PTT                     Interpret with signalment, history (e.g., drug/
                                               toxin exposure) and examination findings,   Specimen Collection and Handling
           Physiology                          other laboratory findings, and other markers   Citrated whole blood (blue top tube) collected
           There is extensive cross talk between the intrin-  of hemostasis (e.g., platelets, PT, fibrinogen)   via atraumatic phlebotomy. Fill to the appropri-  Laboratory Tests
           sic and extrinsic coagulation cascades in vivo.   (p. 433).            ate level (markings may vary by manufacturer).
           Separation of the two in laboratory testing (e.g.,                     Centrifuge and separate plasma within 1 hour,
           PT, aPTT) is artifactual but useful to narrow   Next Diagnostic Steps to Consider   store/ship refrigerated in plastic tube (additive
           differentials for coagulopathy. aPTT screens for   if Levels Are Low   free). If testing > 4 hours from collection, freeze
           deficiencies in intrinsic/contact (PK, XII, XI,   Shortened aPTT cannot be used to confirm   for storage/shipment. Contact laboratory before
           IX, VIII) and common (X, V, II, fibrinogen)   hypercoagulability.      collection as sample handling policy may vary.
           pathway factors and is prolonged when activity
           of a single factor is decreased by 70% or with   Important Interspecies Differences  Relative Cost:  $-$$
           multiple factor deficiencies.       Cats: factor XII deficiency causes prolonga-
                                               tion  in aPTT with  normal  PT and  normal   Pearls
           Reference Interval                  hemostasis. Prolonged aPTT from unknown   •  Low aPTT values do not indicate a proco-
           Laboratory, instrument, and species specific   causes in cats with effective hemostasis has also   agulant state.
           reference intervals must be used. Approximate   been described.        •  Unfractionated heparin will prolong aPTT
           intervals, dogs: 9-17 seconds; cats: 15-19                               but not PT.
           seconds                             Drug Effects                       •  Prolonged aPTT may be seen with a normal
                                               Increased: anticoagulant therapy (e.g., heparin,   PT in the early stages of DIC.
           Causes of Abnormally High Levels    warfarin)
           •  Single factor deficiency: any intrinsic/contact                     AUTHOR: Mary Leissinger, DVM, MS, DACVP
                                                                                  EDITOR: Lois Roth-Johnson, DVM, PhD, DACVP
             or common pathway factor (e.g., hemophilia   Lab Artifacts
             A [VIII], hemophilia B [IX] in dogs, and   •  Shortened or normalized
             XII deficiency in cats)            ○   Inappropriate ratio of plasma to citrate:
           •  Multiple  factor  deficiencies:  disseminated   overfilling citrate tube, severe anemia
             intravascular coagulation (DIC), liver disease   ○   Sample  collection:  difficult/traumatic
             (cholestatic, failure), vitamin K deficiency/  venipuncture






                                                      www.ExpertConsult.com
   2571   2572   2573   2574   2575   2576   2577   2578   2579   2580   2581